Timber Hill’s Edwards Lifesciences EW Stock Holding History

Timber Hill’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-37,500	Closed	-$1.17M	–	2197
2016 Q4	$1.17M	Buy	37,500 +18,900	+102%	+$612K	0.01%	1182
2016 Q3	$747K	Sell	18,600 -30,900	-62%	-$1.16M	﹤0.01%	1274
2016 Q2	$1.65M	Sell	49,500 -21,900	-31%	-$749K	0.01%	995
2016 Q1	$2.1M	Buy	71,400 +36,300	+103%	+$1M	0.01%	900
2015 Q4	$924K	Buy	35,100 +7,500	+27%	+$195K	﹤0.01%	1390
2015 Q3	$654K	Sell	27,600 -22,800	-45%	-$550K	﹤0.01%	1643
2015 Q2	$1.2M	Buy	50,400 +25,800	+105%	+$582K	0.01%	1403
2015 Q1	$584K	Sell	24,600 -22,200	-47%	-$498K	﹤0.01%	1724
2014 Q4	$994K	Sell	46,800 -25,200	-35%	-$506K	﹤0.01%	1445
2014 Q3	$1.23M	Sell	72,000 -84,000	-54%	-$1.33M	0.01%	1455
2014 Q2	$2.23M	Buy	156,000 +18,600	+14%	+$252K	0.01%	1096
2014 Q1	$1.7M	Sell	137,400 -204,600	-60%	-$2.36M	0.01%	1268
2013 Q4	$3.75M	Sell	342,000 -16,800	-5%	-$189K	0.01%	945
2013 Q3	$4.16M	Buy	358,800 +18,000	+5%	+$211K	0.01%	968
2013 Q2	$3.82M	Buy	+340,800	New	+$4.03M	0.01%	987

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Timber Hill's EW Position: Q3 2017 in Review

Timber Hill sold out of Edwards Lifesciences (EW) in Q3 2017, closing a stake of 5,616 shares — an estimated $221K sold.

Timber Hill first reported a position in EW in Q4 2014 and held it in 8 quarters. The position peaked at $1.06M in Q3 2015. 740 funds tracked by Wall St. Rank hold EW as of Q3 2017.

Timber Hill reported no remaining Edwards Lifesciences position as of Q3 2017 after selling out during the quarter.
Timber Hill sold 5,616 Edwards Lifesciences shares in Q3 2017, an estimated $221K.
Timber Hill first reported a position in Edwards Lifesciences in Q4 2014 and held it in 8 quarters.
Timber Hill's Edwards Lifesciences position peaked at $1.06M in Q3 2015.
740 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2017.

Based on Timber Hill's 13F filing for Q3 2017, filed 7 Nov 2017.